These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Comparative efficacy of calcipotriol (MC903) cream and betamethasone 17-valerate cream in the treatment of chronic plaque psoriasis. A randomized, double-blind, parallel group multicentre study. Calcipotriol Study Group. Molin L, Cutler TP, Helander I, Nyfors B, Downes N. Br J Dermatol; 1997 Jan; 136(1):89-93. PubMed ID: 9039301 [Abstract] [Full Text] [Related]
5. Efficacy and safety of a new combination of calcipotriol and betamethasone dipropionate (once or twice daily) compared to calcipotriol (twice daily) in the treatment of psoriasis vulgaris: a randomized, double-blind, vehicle-controlled clinical trial. Guenther L, Van de Kerkhof PC, Snellman E, Kragballe K, Chu AC, Tegner E, Garcia-Diez A, Springborg J. Br J Dermatol; 2002 Aug; 147(2):316-23. PubMed ID: 12174105 [Abstract] [Full Text] [Related]
6. Comparison of calcipotriol monotherapy and a combination of calcipotriol and betamethasone valerate after 2 weeks' treatment with calcipotriol in the topical therapy of psoriasis vulgaris: a multicentre, double-blind, randomized study. Ruzicka T, Lorenz B. Br J Dermatol; 1998 Feb; 138(2):254-8. PubMed ID: 9602870 [Abstract] [Full Text] [Related]
11. Treatment of psoriasis vulgaris with the two-compound product calcipotriol/betamethasone dipropionate followed by different formulations of calcipotriol. Cassano N, Miracapillo A, Coviello C, Loconsole F, Bellino M, Vena GA. Clin Drug Investig; 2006 Feb; 26(4):227-33. PubMed ID: 17163256 [Abstract] [Full Text] [Related]